Lisdexamfetamine dimesylate (LDX) is the first prodrug stimulant used for the treatment of attention-deficit/hyperactivity disorder (ADHD) dosed once daily.

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study.

Key words: attention-deficit/hyperactivity disorder, In a previous 6-week, crossover, classroom analog NRP-104, lisdexamfetamine, stimulant. study in 52 children ag 6dto 12 years with ADHD, is treatment with LDX at 30, 50, or 70 mg was associ-ated …

Data from a long-term, open-label extension study that assessed the safety, tolerability, and efficacy of LDX for up to 12 months found LDX treatment resulted in significant improvement (>60%) from baseline in the ADHD-RS-IV at end point (P < 0.001), with good tolerability.

Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: a phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study

Pill with imprint NRP104 50 mg is Blue & White, Capsule/Oblong and has been identified as Vyvanse 50 mg. It is supplied by Shire US Inc. Vyvanse is used in the treatment of ADHD; Binge Eating Disorder and belongs to the drug class CNS stimulants. Risk cannot be …

2007年3月1日 · Efficacy and tolerability of lisdexamfetamine dimesylate (NRP-104) in children with attention-deficit/hyperactivity disorder: A Phase III, multicenter, randomized, double-blind, forced-dose, parallel-group study *

Lisdexamfetamme dimesylate (LDX) is a therapeutically inactive amphetamine prodrug. It was developed with the goal of providing an extended duration of effect that is consistent throughout the day, with a reduced potential for abuse, overdose toxicity, and drug tampering.

Pill with imprint NRP104 40 mg is Green & White, Capsule/Oblong and has been identified as Vyvanse 40 mg. It is supplied by Shire US Inc. Vyvanse is used in the treatment of ADHD; Binge Eating Disorder and belongs to the drug class CNS stimulants. Risk cannot be …

Objectives: The aims of this study were to assess the efficacy and tolerability of LDX in school-aged children with attention-deficit/hyperactivity disorder (ADHD) treated in the community, and to characterize the duration of action of LDX compared with placebo.